跳至主要内容
临床试验/NCT04217382
NCT04217382已完成不适用

Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2020年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
survival time without melanoma recurrence

研究概览

简要总结

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma.

There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet.

Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with an antecedent of melanoma before transplantation
  • Not opposite to participate

排除标准

  • Under the age of 18
  • patient under Guardianship
  • patient not affiliated with a health system

结局指标

主要结局

survival time without melanoma recurrence

时间窗: at enrollment

Delay in recurrence-free survival since diagnosis and since transplantation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验